You have 9 free searches left this month | for more free features.

zanubrutinib

Showing 1 - 25 of 66

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mantle Cell Lymphoma Trial in Miami, Houston (Zanubrutinib, Tafasitamab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Miami, Florida
  • +1 more
Aug 31, 2023

CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

Not yet recruiting
  • CLL
  • (no location specified)
Oct 3, 2023

Healthy Volunteers Trial in Daytona Beach, Dallas (Zanubrutinib)

Recruiting
  • Healthy Volunteers
  • Zanubrutinib
  • Daytona Beach, Florida
  • +1 more
Mar 15, 2023

Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Jan 23, 2023

Healthy Volunteers Trial in Daytona Beach, Dallas (Zanubrutinib)

Completed
  • Healthy Volunteers
  • Zanubrutinib
  • Daytona Beach, Florida
  • +1 more
Jan 27, 2023

PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

Not yet recruiting
  • PCNSL
  • Zanubrutinib
  • +3 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jun 8, 2023

Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Zanubrutinib
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 14, 2023

Refractory/Relapsed Autoimmune Hemolytic Anemia Trial in Tianjin (Zanubrutinib)

Not yet recruiting
  • Refractory/Relapsed Autoimmune Hemolytic Anemia
  • Zanubrutinib
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Aug 27, 2023

Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)

Not yet recruiting
  • Warm Autoimmune Hemolytic Anemia
  • Zanubrutinib
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 20, 2023

Mantle Cell Lymphoma Trial (drug, biological, other, procedure)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Zanubrutinib
  • +11 more
  • (no location specified)
Jul 26, 2023

Diffuse Large B Cell Lymphoma Trial in Shenyang (Zanubrutinib, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib
  • +5 more
  • Shenyang, Liaoning, China
    Xing Xiaojing
Jun 1, 2023

Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • Zanubrutinib
  • (no location specified)
Nov 28, 2022

Mantle Cell Lymphoma Trial (Zanubrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • (no location specified)
Nov 22, 2022

Splenic Marginal Zone Lymphoma Trial in Worldwide (Rituximab, Zanubrutinib)

Not yet recruiting
  • Splenic Marginal Zone Lymphoma
  • Aarhus, Denmark
  • +4 more
Feb 17, 2023

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Zanubrutinib
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
Oct 23, 2022

CNS Lymphoma Trial in Beijing (Zanubrutinib)

Recruiting
  • CNS Lymphoma
  • Zanubrutinib
  • Beijing, Beijing, China
    Peking University People's Hospital
Aug 1, 2022

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

Relapsed/Refractory Marginal Zone Lymphoma Trial in Westbury (Zanubrutinib, Rituximab, Lenalidomide)

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Zanubrutinib
  • +3 more
  • Westbury, New York
    Clinical Research Alliance, Inc.
Nov 14, 2022

HLH Trial in Beijing (Zanubrutinib)

Recruiting
  • HLH
  • Zanubrutinib
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 2, 2022

Neuromyelitis Optica Trial in Beijing (zanubrutinib)

Recruiting
  • Neuromyelitis Optica
  • zanubrutinib
  • Beijing, Beijing, China
    XuanWu Hospital
May 15, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 30, 2023

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)

Enrolling by invitation
  • Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Mar 22, 2023

Zanubrutinib in Waldenström's Macroglobulinemia (ARIADNE)

Recruiting
  • Waldenström's Macroglobulinemia
  • Zanubrutinib
  • Salzburg, Austria
  • +1 more
May 2, 2022

Lupus Nephritis Trial in Guangdong (Zanubrutinib, Placebo)

Recruiting
  • Lupus Nephritis
  • Zanubrutinib
  • Placebo
  • Guangdong, Guangzhou, China
    Guangdong General Hospital
Apr 19, 2022

Immune Thrombocytopenia, Bruton Tyrosine Kinase Trial in Beijing (Zanubrutinib)

Recruiting
  • Immune Thrombocytopenia
  • Bruton Tyrosine Kinase
  • Zanubrutinib
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Mar 6, 2022